May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Ocular Disease in Patients With Wegener’s Granulomatosis
Author Affiliations & Notes
  • A. S. Watkins
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon
  • J. H. Kempen
    Ophthalmology/Epidemiology & Biostatistics, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania
  • D. Choi
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon
  • J. T. Rosenbaum
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon
  • J. E. Thorne
    Ophthalmology, Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland
  • D. A. Jabs
    Ophthalmology, Mount Sinai School of Medicine, New York, New York
  • R. B. Nussenblatt
    Ophthalmology, National Eye Institute, Bethesda, Maryland
  • C. S. Foster
    Ophthalmology, Massachusetts Eye Research & Surgery Institute, Cambridge, Massachusetts
  • E. B. Suhler
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon
  • J. R. Smith
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon
  • Footnotes
    Commercial Relationships  A.S. Watkins, None; J.H. Kempen, None; D. Choi, None; J.T. Rosenbaum, None; J.E. Thorne, None; D.A. Jabs, None; R.B. Nussenblatt, None; C.S. Foster, None; E.B. Suhler, None; J.R. Smith, None.
  • Footnotes
    Support  NIH Grant EY014943; Research to Prevent Blindness; Paul and Evanina Mackall Foundation
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 800. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. S. Watkins, J. H. Kempen, D. Choi, J. T. Rosenbaum, J. E. Thorne, D. A. Jabs, R. B. Nussenblatt, C. S. Foster, E. B. Suhler, J. R. Smith; Ocular Disease in Patients With Wegener’s Granulomatosis. Invest. Ophthalmol. Vis. Sci. 2008;49(13):800.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Wegeners granulomatosis is a rare multi-system inflammatory disease characterized by necrotizing granulomas and vasculitis. Results from single center studies suggest that the ocular involvement is aggressive, may result in permanent visual loss and often requires treatment with systemic immunosuppression. We investigated clinical aspects of this disease in a cohort of patients drawn from multiple US tertiary-referral inflammatory eye disease clinics.

Methods: : The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) database houses retrospectively collected clinical data from the inflammatory eye disease clinics of Johns Hopkins University, the Massachusetts Eye and Ear Infirmary, the National Eye Institute, Oregon Health & Science University and the University of Pennsylvania. We analyzed data collected on patients with Wegeners granulomatosis, including demographic information, disease characteristics, medical interventions and visual outcomes.

Results: : Of 7547 persons registered in the SITE database on 11/8/07, 13 males and 25 females aged 16 to 75 years (0.5% of total; 0.05% of patients with uveitis; 3% of patients with scleritis; 12% of patients with orbital inflammatory disease) were diagnosed with Wegeners granulomatosis. Average duration of disease was 4.7 years. Primary ocular diagnoses were scleritis (n=27), orbital inflammation (n=7), uveitis (n=3) and unspecified (n=1). Scleritis subtypes included episcleritis (n=2), anterior (n=17), anterior/posterior (n=2) and necrotizing (n=6). For the 38 patients, disease affected one (n=11) or both (n=20) eyes, or was not specified (n=7). Corrected visual acuity was recorded at least once as ≤ 20/50 for 13 patients (34%) and ≤ 20/200 for 4 patients (11%). Commonest identifiable causes of visual loss were cataract, corneal disease, optic neuropathy and active inflammation. Oral corticosteroids were taken by 37 patients (97%), and treatment with systemic immunosuppression was required in 23 cases (61%).

Conclusions: : Wegeners granulomatosis may involve various ocular tissues, most commonly sclera. Our results are consistent with findings of other studies; visual disability and blindness appear to be common, and systemic immunosuppressive medications are frequently used for treatment.

Keywords: inflammation • immunomodulation/immunoregulation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×